Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 26, 2017

DrugPatentWatch Database Preview

Meropenem - Generic Drug Details

« Back to Dashboard

What are the generic sources for meropenem and what is the scope of meropenem freedom to operate?

Meropenem
is the generic ingredient in three branded drugs marketed by Sandoz, Acs Dobfar, Astrazeneca, B Braun Medical Inc, Aurobindo Pharma Ltd, Par Sterile Products, Hospira Inc, Gland Pharma Ltd, Daewoong Pharm Co, Amneal Pharms, and Savior Lifetec Corp, and is included in eleven NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are thirty-one drug master file entries for meropenem. Fourteen suppliers are listed for this compound.

Summary for Generic Name: meropenem

Tradenames:3
Patents:1
Applicants:11
NDAs:11
Drug Master File Entries: see list31
Suppliers / Packagers: see list14
Bulk Api Vendors: see list52
Clinical Trials: see list28
Patent Applications: see list5,526
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:meropenem at DailyMed

Pharmacology for Ingredient: meropenem

Ingredient-typeCarbapenems
Drug ClassPenem Antibacterial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Daewoong Pharm Co
MEROPENEM
meropenem
INJECTABLE;INJECTION204854-001Dec 18, 2015APRXNoNo► Subscribe► Subscribe
Acs Dobfar
MEROPENEM
meropenem
INJECTABLE;INJECTION091404-001Oct 26, 2011APRXNoNo► Subscribe► Subscribe
Savior Lifetec Corp
MEROPENEM
meropenem
INJECTABLE;INJECTION206086-002Apr 19, 2016APRXNoNo► Subscribe► Subscribe
Daewoong Pharm Co
MEROPENEM
meropenem
INJECTABLE;INJECTION204854-002Dec 18, 2015APRXNoNo► Subscribe► Subscribe
Gland Pharma Ltd
MEROPENEM
meropenem
INJECTABLE;INJECTION206141-001Jun 8, 2016APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot